MedTrace Logo

The Effect of Cooling on Sclerotherapy Efficacy

NCT04690803 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-01-05

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the efficacy of sclerotherapy with forced-air cooling during treatment.

Conditions

  • Leg Veins

Interventions

DRUG

air cooling

intervention is adding air-cooling to treatment

Sponsors & Collaborators

  • Goldman, Butterwick, Fitzpatrick and Groff

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-06
Primary Completion
2022-01-01
Completion
2022-12-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04690803 on ClinicalTrials.gov